Rare diseases
Investigational molecules
Locations
Study of nivolumab plus drug combination versus standard first-line therapy in patients with advanced Hodgkin lymphoma
PolandPhase 2 Randomized Study of Povetacicept to Assess Safety and Effectiveness in Adults with Generalized Myasthenia Gravis
PolandLong‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis
PolandRemibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial
PolandAMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment
PolandNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
PolandAUR200 for Patients with Generalized Myasthenia Gravis
PolandICP-332 for Adults with Prurigo Nodularis
PolandRO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes
PolandPhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
PolandLong-Term Study of Imeroprubart in Adults With Graves' Disease
PolandAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
